A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
ConditionHealthy
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorMerck Sharp & Dohme LLC
About this trial
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD).
Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.
Eligibility criteria
Qualifiers
Is in good health
Has a body mass index (BMI) ≥ 18 and ≤ 32 kg/m²
Disqualifiers
Has history of cancer (malignancy)
Has a history of significant multiple and/or severe allergies
Trial design
Treatments tested in this trial
- MK-1403 formulation (FM) 1 + additive
- MK-1403 FM2 + additive
Treatment groups
15 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov